Skip to content

Drug interactions

Pacritinib + Topotecan

Severity: Moderate

Pacritinib and Topotecan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pacritinib inhibits BCRP and may increase exposure to topotecan, a BCRP substrate. Both drugs can also cause cytopenias, compounding hematologic risk.

What this interaction means in plain words

Pacritinib and Topotecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Pacritinib belongs to Oncology; Topotecan belongs to Oncology.

Evidence level: Low

Why it happens

Pacritinib inhibits BCRP efflux of topotecan, with additive myelosuppressive effects.

What to do

Monitor blood counts closely and consider topotecan dose reduction if cytopenias worsen. Avoid with oral topotecan.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pacritinib and Topotecan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Pacritinib with Topotecan?

MediHelp rates the interaction as moderate. Pacritinib and Topotecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pacritinib inhibits BCRP and may increase exposure to topotecan, a BCRP substrate. Both drugs can also cause cytopenias, compounding hematologic risk.

How serious is the interaction between Pacritinib and Topotecan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts closely and consider topotecan dose reduction if cytopenias worsen. Avoid with oral topotecan.

What other medicines interact with Topotecan?

MediHelp also lists interactions of Topotecan with, for example, Adenovirus types 4 and 7 live, Amiodarone, Cisplatin. The full list is on the Topotecan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in